9amHealth, a company dedicated to providing complete cardiometabolic care, has announced it has successfully secured $9.5 million in new investment capital. This significant funding round highlights investor belief in the company's innovative, whole-body approach to managing and preventing chronic conditions such as diabetes, obesity, high cholesterol, and hypertension.
Established in 2021 by the experienced team behind mySugr, 9amHealth distinguishes itself with a comprehensive care model. It offers a first-of-its-kind strategy for addressing the interconnected health challenges of cardiometabolic conditions. The company primarily partners with businesses, enabling them to offer effective health benefits to their employees and members, which in turn helps reduce overall healthcare expenditures. This latest capital infusion follows previous investments from notable firms including 7Wire Ventures, Human Capital, Founders Fund, and Define Ventures, signaling sustained support for 9amHealth's vision.
The newly raised capital will be strategically allocated to accelerate 9amHealth's growth and operational expansion. The company plans to invest in further developing its integrated care platform, enhancing its digital tools, and expanding its clinical team to serve a growing member base. Additionally, funds will support efforts to broaden its partnerships with businesses seeking to improve their health benefits offerings. This investment is expected to significantly bolster 9amHealth's capacity to scale its services and continue its mission of delivering accessible and effective cardiometabolic care to a wider population, addressing a critical need in modern healthcare.
.png&w=3840&q=75)
